Description
Latin name
Betaver
Release form
Tablets.
packaging 20 pcs
Pharmacological action of
Betagistin acts mainly on histamine H1- and H3 receptors of the inner ear and vestibular nuclei of the central nervous system.
Through direct agonistic action on the H1 receptors of the vessels of the inner ear, and also indirectly through the action on the H3 receptors, it improves microcirculation and the permeability of capillaries of the inner ear, normalizes the pressure of the endolymph in the labyrinth and cochlea. However, betahistine increases blood flow in the basilar artery.
It has a pronounced central effect, being an inhibitor of the H3 receptors of the vestibular nerve nuclei. Normalizes the conductivity in neurons of the vestibular nuclei at the level of the brain stem.
The clinical manifestation of these properties is a decrease in the frequency and intensity of dizziness, a decrease in tinnitus, and an improvement in hearing if it is reduced.
Indications
– Treatment and prevention of vestibular dizziness of various origins
– Syndromes including dizziness and headache, tinnitus, progressive hearing loss, nausea and vomiting
– Meniere’s disease / syndrome.
Contraindications
Pregnancy.
Lactation (breastfeeding).
Hypersensitivity to the drug.
Caution: the drug should be prescribed to patients with peptic ulcer of the stomach or duodenum (including history), patients with pheochromocytoma and bronchial asthma.
Use during pregnancy and lactation
There is insufficient data to evaluate the effects of the drug during pregnancy and lactation, so its use during these periods is contraindicated.
Composition
1 tablet contains:
Active ingredient:
betahistine dihydrochloride – 24 mg.
Excipients:
microcrystalline cellulose,
lactose (milk sugar),
corn starch,
polyvinylpyrrolidone (povidone),
sodium carboxymethyl starch (primogel), silyl diclld
Dosage and administration of
The drug is administered orally with food.
Dose / frequency of administration:
Betaver 8 mg – 1-2 tablets 3 times a day.
Betaver 16 mg – 1 / 2-1 tablet 3 times a day.
Improvement is noted already at the beginning of therapy. A stable therapeutic effect is achieved within 2 weeks of taking the drug and can increase when taking the drug for several months.
Duration of therapy is set individually.
Side effects
Possible: violation of the gastrointestinal tract.
In very rare cases: skin manifestations of allergic reactions (skin rash, itching, urticaria), Quincke’s edema.
Drug Interaction
The drug interaction of Betaver with other medicines has not been described.
Cases of incompatibility are unknown.
Overdose
Symptoms: nausea, vomiting when taken at a dose above 640 mg, convulsions may occur.
Treatment: gastric lavage, activated carbon intake, symptomatic therapy.
Storage conditions
At a temperature not exceeding 25 ° C.
Keep out of the reach of children.
Expiration
4 years.
Do not use after the expiry date.
Active ingredient
Betagistin
Conditions of supply of
Pharmacy Prescription
dosage form
dosage form
tablets
